Pancreatic Cancer Research

ResearcherHarold C. Simmons Comprehensive Cancer CenterNo recent work listed

Zachary Moore

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7839-7250; OpenAlex author ID A5047506663. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2015: 4 papers

Papers 4

  1. NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone. Co-author DOI 10.1038/cddis.2014.564↗
  2. Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone. Co-author DOI 10.1038/srep17066↗
  3. Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-15-0744↗
  4. Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ß-lapachone. First author DOI 10.1186/s40170-015-0137-1↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David A. Boothman · 4 shared papers, 2015 · strength 0.18
  2. Gaurab Chakrabarti · 3 shared papers, 2015 · strength 0.13
  3. Rolf A. Brekken · 2 shared papers, 2015 · strength 0.10
  4. Mary Topalovski · 1 shared paper, 2015 · strength 0.05
  5. Diego H. Castrillón · 1 shared paper, 2015 · strength 0.05
  6. Miao Wang · 1 shared paper, 2015 · strength 0.05
  7. Huamin Wang · 1 shared paper, 2015 · strength 0.05
  8. Agnieszka Katarzyna Witkiewicz · 1 shared paper, 2015 · strength 0.05
  9. Molly A. Silvers · 1 shared paper, 2015 · strength 0.04
  10. Lewis C. Cantley · 1 shared paper, 2015 · strength 0.04
  11. Stanton L. Gerson · 1 shared paper, 2015 · strength 0.04
  12. Alec C. Kimmelman · 1 shared paper, 2015 · strength 0.04
  13. Costas Andreas Lyssiotis · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.